RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vioquest Pharmaceuticals Stock

Vioquest Pharmaceuticals Employees 2024

Vioquest Pharmaceuticals Employees

0

Ticker

VOQP

ISIN

US9276252023

In 2024, Vioquest Pharmaceuticals employed 0 people, a 0% change from the 0 number of employees in the previous year.

Vioquest Pharmaceuticals Aktienanalyse

What does Vioquest Pharmaceuticals do?

Vioquest Pharmaceuticals Inc is a company that focuses on the research, development, and marketing of innovative and effective therapies for cancer and other serious diseases. The company was founded in 2003 by Dr. Razelle Kurzrock, one of the country's leading cancer researchers, and is headquartered in New Jersey. The company's history is rooted in the research of drugs and therapies for cancer. The company has made a name for itself in the pharmaceutical industry by producing outstanding innovations. Vioquest Pharmaceuticals aims to offer cancer patients prescription drugs that contain innovative active ingredients and whose effectiveness and tolerability are proven in clinical use. Vioquest Pharmaceuticals' business model is primarily based on the development of drugs for cancer and other serious diseases. The company focuses on the research of drugs that provide long-term support for affected patients and are tailored to their needs. Also listed as "VQPHM," the company has created a broad portfolio of drugs for a variety of cancer types in recent years. Particularly notable is the flagship product Lefitolimod, an immunomodulator used for the treatment of metastatic colon cancer. Another important product is the endothelin receptor antagonist Antineoplaston A10, which has been approved for the treatment of kidney cancer. In addition, the company has achieved further important milestones by expanding its research and development in the field of rare diseases and developing a variety of drugs for the treatment of serious and rare conditions. Vioquest Pharmaceuticals is divided into four different areas: - Clinical Development: This involves researching and developing products that can be tested in later stages in clinical trials. - Science: The science department focuses on the identification of new active ingredients and the investigation of their properties. - Product Development: This involves improving already marketed products to adapt them to the growing needs of patients. - Marketing: This department is responsible for the marketing, distribution, and sale of products. The company has also entered into numerous partnerships in recent years to advance its research and development and ensure effective marketing of its products. Examples include collaboration with Addex Therapeutics to develop a new line of active ingredients for the treatment of multiple cancer types, or collaboration with Premier Research to accelerate the clinical development of Lefitolimod in the United States. The company holds a unique position in the pharmaceutical industry as it is specifically oriented towards the needs of cancer patients. Vioquest Pharmaceuticals has an impressive track record in the development of drugs against cancer and other serious diseases. The focus on patient needs is an important driving force for the company's success. Vioquest Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Vioquest Pharmaceuticals's Employee Base

Vioquest Pharmaceuticals's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Vioquest Pharmaceuticals's operational capacity and future potential.

Year-to-Year Comparison

Assessing Vioquest Pharmaceuticals's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Vioquest Pharmaceuticals's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Vioquest Pharmaceuticals’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Vioquest Pharmaceuticals stock

How many employees does Vioquest Pharmaceuticals have this year?

Vioquest Pharmaceuticals has 0 undefined employees this year.

How many employees did Vioquest Pharmaceuticals have compared to the previous year?

Compared to the previous year, Vioquest Pharmaceuticals had 0% more employees.

What impact did the number of employees have on the company Vioquest Pharmaceuticals?

The number of employees has a direct impact on the efficiency and productivity of Vioquest Pharmaceuticals. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Vioquest Pharmaceuticals?

The number of employees can also have an impact on investors of Vioquest Pharmaceuticals, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Vioquest Pharmaceuticals affect the company?

An increase in equity of Vioquest Pharmaceuticals can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Vioquest Pharmaceuticals's equity affect the company?

A reduction in equity of Vioquest Pharmaceuticals can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Vioquest Pharmaceuticals?

Some factors that can influence the equity of Vioquest Pharmaceuticals include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Vioquest Pharmaceuticals so important for investors?

The equity of Vioquest Pharmaceuticals is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Vioquest Pharmaceuticals influence the company?

The number of employees at Vioquest Pharmaceuticals can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Vioquest Pharmaceuticals evolved in recent years?

In recent years, the number of employees at Vioquest Pharmaceuticals has changed by NaN.

How many employees does Vioquest Pharmaceuticals currently have?

Vioquest Pharmaceuticals currently has 0 undefined employees.

Why is the number of employees important for investors of Vioquest Pharmaceuticals?

The number of employees is important for investors of Vioquest Pharmaceuticals as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Vioquest Pharmaceuticals take to change the number of employees?

To change the number of employees, Vioquest Pharmaceuticals can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Vioquest Pharmaceuticals pay?

Over the past 12 months, Vioquest Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Vioquest Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Vioquest Pharmaceuticals?

The current dividend yield of Vioquest Pharmaceuticals is .

When does Vioquest Pharmaceuticals pay dividends?

Vioquest Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Vioquest Pharmaceuticals?

Vioquest Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Vioquest Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Vioquest Pharmaceuticals located?

Vioquest Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Vioquest Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vioquest Pharmaceuticals from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.

When did Vioquest Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/9/2024.

What was the dividend of Vioquest Pharmaceuticals in the year 2023?

In the year 2023, Vioquest Pharmaceuticals distributed 0 USD as dividends.

In which currency does Vioquest Pharmaceuticals pay out the dividend?

The dividends of Vioquest Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Vioquest Pharmaceuticals

Our stock analysis for Vioquest Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vioquest Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.